Table 3.
Group | Men | Women |
---|---|---|
Retinopathy (NDR/SDR/PDR) | 170 (100 to 250)/190 (120 to 290)/190 (110 to 340)a | 150 (90 to 220)/130 (80 to 200)/150 (90 to 250) |
Nephropathy (normo-/micro-/macroalbuminuria) | 140 (90 to 210)/190 (120 to 310)/250 (170 to 350)b | 150 (90 to 210)/140 (90 to 220)/170 (90 to 320) |
Smoking (none/past/current) | 160 (110 to 270)/180 (110 to 290)/170 (100 to 250) | 150 (90 to 220)/130 (60 to 220)/150 (110 to 290) |
Cardiovascular disease (−/+) | 170 (100 to 280)/190 (130 to 280) | 150 (90 to 230)/140 (90 to 180) |
Insulin treatment (−/+) | 160 (100 to 270)/190 (110 to 280) | 150 (90 to 210)/150 (90 to 240) |
Data are median (interquartile range).
P < 0.05.
P < 0.0001.